Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ravits

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
A double-blind trial of isoniazid for essential tremor and other action tremorsM Hallett, J Ravits, R M Dubinsky, et al.
The New England Journal of Medicine|April 10, 1986
A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptomsM C Dalakas, G Elder, M Hallett, et al.
Neurology|August 23, 2000
Late-onset SCA2: 33 CAG repeats are sufficient to cause diseaseM Fernandez, M E McClain, R A Martinez, et al.
Neurology|April 11, 2001
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosisR G Miller, D H Moore, D F Gelinas, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
A double-blind trial of isoniazid for essential tremor and other action tremorsM Hallett, J Ravits, R M Dubinsky, et al.
The New England Journal of Medicine|April 10, 1986
A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptomsM C Dalakas, G Elder, M Hallett, et al.
Neurology|August 23, 2000
Late-onset SCA2: 33 CAG repeats are sufficient to cause diseaseM Fernandez, M E McClain, R A Martinez, et al.
Neurology|April 11, 2001
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosisR G Miller, D H Moore, D F Gelinas, et al.
Pageof 2